spacer
home > ebr
PUBLICATIONS

European Biopharmaceutical Review

 

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.

With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:

Advertising
David Hirsh 

Editorial 
Emma Naks


View the
digital version
of EBR


ebr
 
 
Featured in this issue
BioDevelopment
Inter-Species Safety

Advancing Xenogeneic Therapy

Peter Gaskin and Kathryn Parsley from PPD examine the growing body of work on the non-clinical testing strategies for xenogeneic products, enabling the safe progression of products from animal models into clinical studies.

CANCER FOCUS
HPV-Related Cancers

Infection Control

With more HIV-positive individuals facing a growing risk of HPV-related cancers, Eyal Talor at CEL-SCI Corporation stresses the need for further research, such as a recent study looking at immunotherapy against AIN in co-infected subjects.
  REGIONAL UPDATES
In Brief

Follow the Money

Emile Bellott explores the rising tide of biomedical R&D in East Asia – and how it may impact future generations of biotech companies.

spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July and October

Banner of Samedan app.EBR on Samedan
Banner of TCS.EBR on Samedan
 
Industry Events

HPLC 2014 New Orleans

11-15 May 2014, New Orleans, LA, USA

Don't miss the Largest International Liquid-phase Separations Conference and Exhibition of the Year, HPLC 2014 on May 11-15, 2014 in New Orleans, LA, USA. 
More info >>

 
News and Press Releases

Woodley Equipment Announces the Appointment of Claire Lever

Woodley Equipment Company is pleased to announce the appointment of Claire Lever as Account Manager in our Clinical Trials Division. Claire has experience of providing high quality customer service gained from working in similar account manager roles.
More info >>

air transport logo

 

White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement